In this randomized controlled trial, adjuvant therapy with durvalumab led to improved overall and progression-free survival ...

Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...

As Ahmet F. Coskun and his team of researchers continue their mission to create a 3D atlas of the human body, mapping cells and tissues, they're ...

Zorifertinib is the first drug in the world to launch a registration clinical trial specifically for advanced NSCLC with CNS metastases and achieve remarkable results. It is also the only* EGFR ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 ... Scientists Discover That ...

European Union recommends approval of AstraZeneca’s Tagrisso for patients with unresectable EGFR-mutated lung cancer ...

Well, I am a non-smoker, and in November of 2023 I was diagnosed with stage 4 non-small cell lung cancer. "I have a husband and three young kids – nine, six and three – and to say that it has ...

There are two main types of lung cancer. Most lung cancers are called non-small cell lung cancer (NSCLC). This group includes: adenocarcinoma squamous cell carcinoma large cell carcinoma ALK ...

No filter, high-puff frequency, higher quantities of nicotine and tar in bidi The Tribune, now published from Chandigarh, ...

Genprex intellectual property and licensing senior vice-president Thomas Gallagher stated: “We continue to bolster our intellectual property portfolio for REQORSA, understanding ...

Pyxis Oncology shares dropped 40% after phase 1 data on PYX-201 for solid tumors, as one participant death raises concern.

Lung12, patients will be screened with the GRAIL assay prior to surgery to inform eligibility for post-surgery randomization to an adjuvant treatment regimen ( NCT06564844 ). Assay performance was ...